Guangdong Marubi Biotechnology Balance Sheet Health
Financial Health criteria checks 5/6
Guangdong Marubi Biotechnology has a total shareholder equity of CN¥3.4B and total debt of CN¥250.9M, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are CN¥4.4B and CN¥991.3M respectively. Guangdong Marubi Biotechnology's EBIT is CN¥264.8M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥2.1B.
Key information
7.3%
Debt to equity ratio
CN¥250.91m
Debt
| Interest coverage ratio | -4.6x |
| Cash | CN¥2.10b |
| Equity | CN¥3.44b |
| Total liabilities | CN¥991.30m |
| Total assets | CN¥4.44b |
Recent financial health updates
Recent updates
Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?
Nov 22
Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher
Sep 26Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations
Aug 30Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Jun 19Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet
May 29Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Financial Position Analysis
Short Term Liabilities: 603983's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥969.6M).
Long Term Liabilities: 603983's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥21.7M).
Debt to Equity History and Analysis
Debt Level: 603983 has more cash than its total debt.
Reducing Debt: 603983's debt to equity ratio has increased from 0% to 7.3% over the past 5 years.
Debt Coverage: 603983's debt is well covered by operating cash flow (134.9%).
Interest Coverage: 603983 earns more interest than it pays, so coverage of interest payments is not a concern.